152 related articles for article (PubMed ID: 33662150)
1. Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
Narusaka T; Ohara T; Noma K; Nishiwaki N; Katsura Y; Kato T; Sato H; Tomono Y; Kikuchi S; Tazawa H; Shirakawa Y; Matsukawa A; Fujiwara T
Int J Cancer; 2021 Jul; 149(2):347-357. PubMed ID: 33662150
[TBL] [Abstract][Full Text] [Related]
2. Nicotine-Induced ILF2 Facilitates Nuclear mRNA Export of Pluripotency Factors to Promote Stemness and Chemoresistance in Human Esophageal Cancer.
Li Y; Wang M; Yang M; Xiao Y; Jian Y; Shi D; Chen X; Ouyang Y; Kong L; Huang X; Bai J; Hu Y; Lin C; Song L
Cancer Res; 2021 Jul; 81(13):3525-3538. PubMed ID: 33975879
[TBL] [Abstract][Full Text] [Related]
3. Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo.
Ford SJ; Obeidy P; Lovejoy DB; Bedford M; Nichols L; Chadwick C; Tucker O; Lui GY; Kalinowski DS; Jansson PJ; Iqbal TH; Alderson D; Richardson DR; Tselepis C
Br J Pharmacol; 2013 Mar; 168(6):1316-28. PubMed ID: 23126308
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Iron Chelators on the Biology of Cancer Stem Cells.
Szymonik J; Wala K; Górnicki T; Saczko J; Pencakowski B; Kulbacka J
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008527
[TBL] [Abstract][Full Text] [Related]
5. siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin.
Alemohammad H; Motafakkerazad R; Asadzadeh Z; Farsad N; Hemmat N; Najafzadeh B; Vasefifar P; Baradaran B
Gene; 2022 May; 821():146333. PubMed ID: 35182674
[TBL] [Abstract][Full Text] [Related]
6. Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer.
Wang H; Liu B; Wang J; Li J; Gong Y; Li S; Wang C; Cui B; Xue X; Yang M; Fan W; Kang Z; Kamran M; Xu J; Tian P; Luo Y; Hou Z; Dong L; Ren Y; Li M; Wen Q; Cheng W; Xu L; Wang L; Liu Q
Cell Physiol Biochem; 2017; 44(3):1051-1063. PubMed ID: 29179207
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin induces stemness in ovarian cancer.
Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O
Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520
[TBL] [Abstract][Full Text] [Related]
8. Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG.
Zhao H; Li N; Pang Y; Zhao J; Wu X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313950
[TBL] [Abstract][Full Text] [Related]
9. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
10. ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.
Chen Q; Song S; Wei S; Liu B; Honjo S; Scott A; Jin J; Ma L; Zhu H; Skinner HD; Johnson RL; Ajani JA
Oncotarget; 2015 Sep; 6(28):25883-96. PubMed ID: 26317542
[TBL] [Abstract][Full Text] [Related]
11. In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancer.
Huang TH; Wu ATH; Cheng TS; Lin KT; Lai CJ; Hsieh HW; Chang PM; Wu CW; Huang CF; Chen KY
J Cell Mol Med; 2019 Dec; 23(12):8184-8195. PubMed ID: 31638335
[TBL] [Abstract][Full Text] [Related]
12. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
13. The iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment.
Wang L; Li X; Mu Y; Lu C; Tang S; Lu K; Qiu X; Wei A; Cheng Y; Wei W
J Trace Elem Med Biol; 2019 Dec; 56():131-138. PubMed ID: 31466045
[TBL] [Abstract][Full Text] [Related]
14. Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial-Mesenchymal Transition and Stemness in Esophageal Carcinoma.
Huang CM; Huang CS; Hsu TN; Huang MS; Fong IH; Lee WH; Liu SC
Cells; 2019 Dec; 9(1):. PubMed ID: 31861383
[No Abstract] [Full Text] [Related]
15. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of TAZ decrease the cancer stem properties of ESCC cell line YM-1 by modulation of Nanog, OCT-4 and SOX2.
Khosravi A; Jafari SM; Asadi J
Gene; 2021 Feb; 769():145207. PubMed ID: 33031893
[TBL] [Abstract][Full Text] [Related]
17. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells.
Jiang P; Xu C; Chen L; Chen A; Wu X; Zhou M; Haq IU; Mariyam Z; Feng Q
Mol Carcinog; 2018 Dec; 57(12):1835-1844. PubMed ID: 30182373
[TBL] [Abstract][Full Text] [Related]
18. RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog.
Cao J; Zhao M; Liu J; Zhang X; Pei Y; Wang J; Yang X; Shen B; Zhang J
Theranostics; 2019; 9(3):811-828. PubMed ID: 30809310
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
[TBL] [Abstract][Full Text] [Related]
20. The oncogenic potential of NANOG: An important cancer induction mediator.
Najafzadeh B; Asadzadeh Z; Motafakker Azad R; Mokhtarzadeh A; Baghbanzadeh A; Alemohammad H; Abdoli Shadbad M; Vasefifar P; Najafi S; Baradaran B
J Cell Physiol; 2021 Apr; 236(4):2443-2458. PubMed ID: 32960465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
